Welcome to our dedicated page for Modular Medical SEC filings (Ticker: MODD), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Modular Medical, Inc. filings document a Nevada medical device issuer developing insulin delivery technology, including registration statements, material-event reports, shareholder approvals, and capital-structure changes. Disclosures cover common stock, warrants and pre-funded warrants, amendments to authorized shares, and the completed one-for-thirty reverse stock split.
MODD filings also record material agreements and financing arrangements, Nasdaq continued-listing matters, operating expense reductions, governance actions, risk-related disclosures, and securities registration information for the company’s Pivot-focused insulin pump business.
Modular Medical, Inc. director Steven G. Felsher received equity compensation consisting of common shares and stock options. He was granted 25 shares of common stock at a stated price of $0.0000 per share under the company’s Outside Director Compensation Plan, bringing his direct common stock holdings to 8,498 shares.
He was also granted an option to purchase 250 shares of common stock at an exercise price of $4.88 per share, expiring on June 30, 2036. The option was fully vested and exercisable on the grant date. Share amounts reflect a 1-for-30 reverse stock split of the company’s common stock effected on March 31, 2026.
Modular Medical, Inc. director Carmen B. Volkart received a grant of common stock as part of board compensation. On the reported date, Volkart acquired 110 shares of common stock at a price of $0.00 per share, increasing direct holdings to 916 shares. The shares were issued under the company’s Outside Director Compensation Plan, and the reported share amounts reflect the impact of a 1-for-30 reverse stock split of the common stock that was effected on March 31, 2026.
Modular Medical, Inc. director Duane M. DeSisto received a grant of common stock under the company’s Outside Director Compensation Plan. He acquired 83 shares at a price of $0.00 per share and now directly holds 8,627 common shares. A 1-for-30 reverse stock split on March 31, 2026 affected the reported share amounts.
Modular Medical, Inc. director and 10% owner C. Frank Morgan received new stock option awards as part of his outside director compensation. On June 30, 2026, he was granted options for 250 shares of common stock and a separate grant for 62 shares, each with an exercise price of $4.88 per share. The footnotes state these options were granted under the company’s Outside Director Compensation Plan and were fully vested and exercisable on the grant date. Following the grants, his reported beneficial ownership for these option classes is 312 options for one class and 62 options for the other.
Modular Medical is an early commercial-stage diabetes device company focused on simple, low-cost insulin pumps for “Almost Pumpers” who currently rely on multiple daily injections. The company received FDA clearance for its original MODD1 pump in September 2024 and for its next‑generation Pivot patch pump in April 2026, but plans to commercialize only Pivot.
Pivot is a tubeless, 3 mL patch pump designed to be easier to learn and cheaper to manufacture, using contract production through Phillips Medisize. Initial U.S. shipments began in June 2026, with plans to expand across metropolitan markets by late 2026 and pursue CE mark clearance by the second quarter of 2027 for European and other markets.
Financially, the company remains under significant strain. As of March 31, 2026, it reported cash and cash equivalents of $6.9 million and an accumulated deficit of $113.0 million. It closed an additional public offering in April 2026 for about $3.0 million, yet management states this will still not fund operations for the next 12 months. Net losses were approximately $28.2 million in fiscal 2026 and $18.8 million in fiscal 2025, and the filing explicitly raises substantial doubt about the company’s ability to continue as a going concern without further capital.
Modular Medical, Inc. disclosed new stock option awards for two senior executives. On May 14, 2026, the board granted 11,218 stock options to Chairman, President, Chief Financial Officer and Treasurer Paul DiPerna and 4,674 stock options to Chief Operating Officer Kevin Schmid.
The options carry an exercise price of $3.46 per share, vest with one-third of the shares on May 14, 2027 and the remaining shares vesting monthly over the following 24 months, contingent on continued service. The options expire on May 14, 2036 and were issued under the company’s Amended and Restated 2017 Equity Incentive Plan.
Modular Medical, Inc. reported that company officer Paul DiPerna received a grant of stock options as part of his compensation. He was awarded options to purchase 11,218 shares of common stock at an exercise price of $3.46 per share, expiring on May 14, 2036. One third of the options will vest on May 14, 2027, with the remaining portion vesting in equal monthly installments over the following 36 months. After this grant, DiPerna holds 11,218 options of this class directly.
Modular Medical, Inc. reported that its Chief Operating Officer, Kevin Schmid, received a grant of options to purchase 4,674 shares of common stock. The options have an exercise price of $3.46 per share and expire on May 14, 2036.
According to the grant terms, one-third of the option shares will vest on May 14, 2027, with the remaining shares vesting in equal monthly installments of 1/36th thereafter. Following this grant, Schmid holds 4,674 options of this derivative security directly.
Modular Medical, Inc. ownership update: Solas Capital Management, LLC and portfolio manager Frederick Tucker Golden report beneficial ownership of 464,850 shares of Common Stock, representing approximately 9.6% of the class. The position comprises 288,095 shares of Common Stock and 176,755 shares issuable upon exercise of warrants, based on 4,660,360 shares outstanding as of March 31, 2026. The filing states shared voting and dispositive power over all 464,850 shares and disclaims beneficial ownership by the underlying funds under Rule 13d-4.
Modular Medical, Inc. reports that 683 Capital Partners, LP (through its manager 683 Capital Management, LLC and Managing Member Ari Zweiman) beneficially owned 125,001 common shares and warrants exercisable for 134,239 shares. The filing states this position represents approximately 4.67% of the outstanding common stock, based on 5,411,177 shares outstanding as of April 21, 2026, with the 4.67% figure given as of May 15, 2026.